Tele: 561.316.3330
Breaking Medical Device News

Monday, September 27, 2021
HomeFUNDINGSheltowee Medical Device Fund Breaks Escrow Making Its 1st Investment in Embolic Acceleration, LLC

Sheltowee Medical Device Fund Breaks Escrow Making Its 1st Investment in Embolic Acceleration, LLC

November 12, 2020

Sheltowee Medical Device Fund, LP (SMDF) broke escrow and made its first investment in Embolic Acceleration, LLC (EMBA) of Miramar, FL, recently. The SMDF is a $20M venture fund dedicated to investing in the best and brightest medical devices and entrepreneurs in the “heartland” of the U.S.

Sheltowee Medical Device Fund investment thesis is to target seed and early stage medical device companies in the cardiovascular, orthopedics, and digital wearables market segments, all areas of expertise by the leadership team and Scientific Advisory Board of the fund. The fund will target five investments per year for five years. Each portfolio company will be actively engaged by the Leadership Team and be integrated into an ecosystem of innovation, product development, and product commercialization.

Brian Doughty, SMDF Partner, stated, “These companies must have clear intellectual property value, a clear path to commercialization, and be ready to embrace the DeltaForceTM method.”  This method is a key efficiency driver that has been demonstrated to propel companies through their early, awkward stages faster and more cost-effectively than traditional venture investment models for medical devices. “EMBA scored well on our 15-point structural diligence report and equally well on our 217-point market acceptance risk report,” said Doughty. “We have high expectations of the company,” he added.

“We are excited about what we have been able to accomplish this year in the midst of the turmoil of 2020,” stated Dobson. “We expect to fully capitalize the fund shortly and expand our impact,” he added. Dobson further stated, “We are thrilled we were able to break escrow, make our first investment, create such an outstanding Scientific Board of Advisors this year.  We expect to make one more investment before year end. And, 2021 is shaping up to be a great year for Sheltowee.”

The SMDF is expected to be fully capitalized in early 2021. Investors interested in information should contact Eric Dobson, listed below.

Medical Device News Magazine
Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Stay Connected


Don't Miss

Tyber Medical Reaches Agreement to Acquire CatapultMD

Once the acquisition is complete, Tyber Medical will own and operate a combined 100,000-square feet of manufacturing space between its Pennsylvania headquarters and Florida-based facilities.

Kleiner Device Labs Receives FDA Market Clearance for KG2 Surge Flow-Thru Interbody System

The system maximizes total bone graft delivery volume, better distributes graft bilaterally into the intervertebral disc space, and streamlines the implant delivery, positioning, and grafting process for TLIF and PLIF spinal fusion procedures.

Matthew Cranfill New ExtriCARE USA Director Of Clinical Services

"Matt's impressive experience and skillset easily made him our top pick," said Peter Mason, President of ExtriCARE USA.

FDA Authorizes Software that Can Help Identify Prostate Cancer

The software is called Paige Prostate and is compatible for use with slide images that have been digitized using a scanner.

Shannon Lantzy MedCrypt New VP of Consulting

"I met Shannon at a healthcare-related event several years ago and was immediately impressed with her passion and drive to move healthcare into a digital future," said Mike Kijewski, CEO of MedCrypt.

Mark Foster Joins Xenocor BOD

Foster is a versatile and visionary C-Suite executive who brings 20 years of general management and leadership experience from both venture-backed growth-stage organizations and world-class medical device companies

Hinge Health Acquires the Most Advanced Computer Vision Technology for Tracking Human Motion

CEO Daniel Perez explained, “We won’t stop investing in technology to deliver the most patient-centered digital clinic that improves member experience and outcomes while reducing costs. wrnch allows us to take a giant leap forward in all respects.”

Dale W Wood Congratulates the Huma Team on Raising $130 Million

Major health and technology companies across the world have committed upwards of $130 million to Huma Therapeutics, the health-tech company backed by Dale Ventures.

By using this website you agree to accept Medical Device News Magazine Privacy Policy